A study of 3,992 breast cancer patients showed that CD8+ tumor infiltrating lymphocytes was an independent indicator related with good survival in patients with basal-like breast cancer, but not patients with other intrinsic molecular subtypes (27). This evidence concerns the gene CD8A and breast cancer.